ArticleEBioMedicine2025
Proteomics insights: exploring the inflammatory and metabolic signatures of ethnicity and change in physical activity in non-diabetic hyperglycaemia.
Article in EBioMedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- PBMC transcriptomic signatures reflect immune dynamics and disease activity in psoriatic arthritis.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPeople of South Asian (SA) origin have an elevated risk of cardiometabolic dysfunction and respond differentially to physical activity. Mechanisms underpinning these observations are incompletely understood. We investigated protein signatures of ethnicity, changing physical activity and their interaction.
methodsA discovery analysis was conducted using data from 794 SA to 49,153 white European (WE) participants in UK Biobank, assessing associations between 726 plasma proteins and physical activity and ethnicity. Findings were validated in a targeted cohort of 58 individuals with non-diabetic hyperglycaemia, taken from a larger randomised controlled trial (PROPELS, n = 1366), stratified by ethnicity and changes in accelerometer assessed physical activity (steps/day) over 48 months. Individuals matched for ethnicity, age and sex that increased and decreased their physical activity over time were sampled, creating four groups (SA increasers [n = 15], SA decreasers [n = 15], WE increasers [n = 14], WE decreasers [n = 14]). Proteins were analysed using Olink inflammation and cardiovascular panels.
findingsIn the discovery phase, 464 proteins were associated with physical activity and 375 with ethnicity. In the validation cohort, only interleukin-6 (IL-6) was significantly associated with physical activity, showing downregulation in those who increased activity. Sixteen proteins were validated for ethnicity, including upregulated chemokines (e.g., CCL28, CCL15, CCL13, CCL11, CCL26), hepatokines (FABP1), adipokines (FABP2), and pancreatic proteins (AMY2A, AMY2B), with CXCL14, GHRL and PRTN3 downregulated in SAs.
interpretationDistinct proteomic profiles were associated with ethnicity and physical activity. IL-6 emerged as a key marker of physical activity response, while ethnicity-related proteins highlighted immune, inflammatory, and metabolic pathways.
fundingNIHR Leicester Biomedical Research Centre.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.